Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > IBN Develops Novel Injectable Hydrogel with Tunable Stiffness for Tissue Repair and Regeneration

Formation of Gtn–HPA hydrogels by enzyme-catalyzed oxidation for (a) 3D and (b) 2D cell growth/differentiation.
Formation of Gtn–HPA hydrogels by enzyme-catalyzed oxidation for (a) 3D and (b) 2D cell growth/differentiation.

Abstract:
Scientists at the Institute of Bioengineering and Nanotechnology (IBN), the world's first bioengineering and nanotechnology research institute, have developed the first injectable hydrogel system with variable stiffness that can control cell proliferation and differentiation in a two-dimensional (2D) and threedimensional (3D) cell culture environment. This unique hydrogel invention has important tissue engineering applications, especially in the treatment of neurological disorders, brain and muscle injuries (*).

IBN Develops Novel Injectable Hydrogel with Tunable Stiffness for Tissue Repair and Regeneration

Singapore | Posted on December 17th, 2010

Human mesenchymal stem cells (hMSCs) are commonly used in cell therapies because they are easy to isolate and handle. hMSCs can differentiate into multiple cell types, such as osteoblasts (bone cells), neurons (nerve cells) and cardiac myocytes (heart muscle cells) via cell culture. The use of hydrogels as scaffolds for the cultivation of hMSCs is attractive because the former's high water content matrix provides high permeability for oxygen, nutrients and other water-soluble metabolites. This quality makes them an excellent environment for cell growth and tissue regeneration. In addition, hydrogels can administer cells to the precise locations in the body for tissue repair and regeneration.

Hydrogel stiffness directly affects cell proliferation and differentiation, and a major challenge of existing injectable hydrogel systems lies in controlling the hydrogel's stiffness without affecting its gelation rate. Hydrogels are formed via a crosslinked polymer network and control over the gelation rate is presently limited to varying the polymer precursor solution, which changes the stiffness but is undesirable for controlling cell growth and differentiation. This means that when hydrogels with low stiffness are formed from a low concentration of polymer precursor, the gelation rate will be correspondingly slower. For an injectable hydrogel system, it is important for the hydrogel to be formed rapidly after injection, to prevent the unwanted diffusion of the gel precursors and cells to the surrounding tissues.

To overcome this limitation, IBN has developed a novel injectable hydrogel system composed of biodegradable gelatin-hydroxyphenylpropionic acid (Gtn-HPA) conjugates that provides independent control over the stiffness and gelation rate of the hydrogel. The Gtn-HPA hydrogels were formed via an enzyme-mediated oxidation reaction with hydrogen peroxide (H2O2) and horseradish peroxidase (HRP), which determined the stiffness and gelation rate, respectively. By modifying the H2O2 concentration, the mechanical strength of the Gtn-HPA hydrogels can be altered without changing the polymer precursor solution and affecting its gelation rate over a wide range of stiffness. In the 2D and 3D culture setting, IBN researchers found that the proliferation of hMSCs inside the hydrogel increased with a decrease in stiffness and the neurogenesic differentiation was also enhanced when the cells were cultured in hydrogels with lower stiffness.

Additionally, IBN's injectable hydrogel system is synthesized without toxic chemicals, allowing bioactive molecules, such as therapeutic proteins, growth factors and cells to be encapsulated in the hydrogels without being damaged. This biodegradable system allows the hydrogels to be formed without causing any inflammatory response in the body.

"With its readily tunable mechanical properties and excellent performance as a cell growth support, our injectable Gtn-HPA hydrogel system has demonstrated its suitability as a tissue engineering scaffold. Our research findings show the importance of a suitable material system and the influence of physical parameters in addition to biological and chemical parameters for effective tissue repair and regeneration. Our hydrogels' excellent cell adhesion and their optical transparency also make them suitable for tissue engineering applications," said Dr Motoichi Kurisawa, IBN Team Leader and Principal Research Scientist, who led this research effort.

"Developing new approaches to medical treatments using next-generation materials is a key research thrust in IBN. This latest biomaterial innovation from our scientists offers a promising breakthrough, particularly for the advancement of stem cell-based in vivo therapies. We are now able to deliver a simple and biocompatible system to advance tissue engineering and drug delivery applications," added Professor Jackie Y. Ying, IBN Executive Director.

(*) References:
1. L. S. Wang, J. Boulaire, P. P. Y. Chan, J. E. Chung and M. Kurisawa, "The Role of Stiffness of Gelatin-Hydroxyphenylpropionic Acid Hydrogels Formed by Enzyme- Mediated Crosslinking on the Differentiation of Human Mesenchymal Stem Cell," Biomaterials, 31 (2010) 8608-8616.
2. L. S. Wang, P. P. Y. Chan, J. E. Chung and M. Kurisawa, "Injectable Biodegradable Hydrogels with Tunable Mechanical Properties for the Stimulation of Neurogenesic Differentiation of Human Mesenchymal Stem Cells in 3D Culture," Biomaterials, 31 (2010) 1148-1157.

####

About Institute of Bioengineering and Nanotechnology
The Institute of Bioengineering and Nanotechnology (IBN) was established in 2003 and is spearheaded by its Executive Director, Professor Jackie Yi-Ru Ying, who has been on the Massachusetts Institute of Technology’s Chemical Engineering faculty since 1992, and was among the youngest to be promoted to Professor in 2001.In 2008, Professor Ying was recognized as one of “One Hundred Engineers of the Modern Era” by the American Institute of Chemical Engineers for her groundbreaking work on nanostructured systems, nanoporous materials and host matrices for quantum dots and wires. Under her direction, IBN conducts research at the cutting-edge of bioengineering and nanotechnology. Its programs are geared towards linking multiple disciplines across all fields in engineering, science and medicine to produce research breakthroughs that will improve healthcare and our quality of life.

For more information, please click here

Contacts:
Media Contacts:
Elena Tan
Tel: 65 6824 7032


Nidyah Sani
Tel: 65 6824 7005

Copyright © Institute of Bioengineering and Nanotechnology

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Harris & Harris Group to Host Conference Call on Second-Quarter 2014 Financial Results on August 15, 2014 July 23rd, 2014

UCF Nanotech Spinout Developing Revolutionary Battery Technology: Power the Next Generation of Electronics with Carbon July 23rd, 2014

Deadline Announced for Registration in 7th Int'l Nanotechnology Festival in Iran July 23rd, 2014

A Crystal Wedding in the Nanocosmos July 23rd, 2014

Possible Futures

IBM Announces $3 Billion Research Initiative to Tackle Chip Grand Challenges for Cloud and Big Data Systems: Scientists and engineers to push limits of silicon technology to 7 nanometers and below and create post-silicon future July 10th, 2014

Virus structure inspires novel understanding of onion-like carbon nanoparticles April 10th, 2014

Local girl does good March 22nd, 2014

Surface Characteristics Influence Cellular Growth on Semiconductor Material March 12th, 2014

Academic/Education

Haydale Announces Collaboration Agreement with Swansea University’s Welsh Centre for Printing and Coatings (WCPC) July 12th, 2014

STFC takes delivery of the 100th Hitachi Tabletop SEM in the UK July 3rd, 2014

Innovation Management and the Emergence of the Nanobiotechnology Industry July 1st, 2014

Albany NanoCollege Faculty Member Selected as Editor-in-Chief of the Prestigious Journal of Electronic Materials July 1st, 2014

Nanomedicine

Researchers create vaccine for dust-mite allergies Main Page Content: Vaccine reduced lung inflammation to allergens in lab and animal tests July 22nd, 2014

NIST shows ultrasonically propelled nanorods spin dizzyingly fast July 22nd, 2014

SentiMag® Now Available in Australia and New Zealand July 21st, 2014

More than glitter: Scientists explain how gold nanoparticles easily penetrate cells, making them useful for delivering drugs July 21st, 2014

Announcements

Harris & Harris Group to Host Conference Call on Second-Quarter 2014 Financial Results on August 15, 2014 July 23rd, 2014

UCF Nanotech Spinout Developing Revolutionary Battery Technology: Power the Next Generation of Electronics with Carbon July 23rd, 2014

Deadline Announced for Registration in 7th Int'l Nanotechnology Festival in Iran July 23rd, 2014

A Crystal Wedding in the Nanocosmos July 23rd, 2014

Nanobiotechnology

Production of Non-Virus Nanocarriers with Highest Amount of Gene Delivery July 17th, 2014

Physicists Use Computer Models to Reveal Quantum Effects in Biological Oxygen Transport: The team solved a long-standing question by explaining why oxygen – and not deadly carbon monoxide – preferably binds to the proteins that transport it around the body. July 17th, 2014

Tiny DNA pyramids enter bacteria easily -- and deliver a deadly payload July 9th, 2014

Artificial cilia: Scientists from Kiel University develop nano-structured transportation system July 4th, 2014

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE